Future vaccination strategies against tuberculosis: thinking outside the box

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• Tuberculosis (TB) remains a significant global health challenge.
• Current TB vaccine development is progressing with multiple candidates in clinical trials.
• Existing vaccines have limitations in preventing infection and disease reactivation.

Purpose of the Study:

• To review current and future strategies for rational vaccine design against tuberculosis.
• To discuss progress and challenges in TB vaccine research and development.
• To highlight the importance of translational research in advancing TB vaccine efficacy.

Main Methods:

• Review of existing literature on TB vaccine candidates and clinical trials.
• Analysis of immunological and vaccinology approaches for TB control.
• Discussion of translational and reverse-translational research models.

Main Results:

• Several TB vaccine candidates are in clinical trials, showing promise in preventing disease reactivation.
• The pathogen Mycobacterium tuberculosis (Mtb) is the target of these vaccine efforts.
• The need for vaccines achieving sterile eradication or preventing stable infection is emphasized.

Conclusions:

• Translational research, integrating basic immunology with clinical development, is crucial for advancing TB vaccines.
• Future TB vaccine strategies must aim for more robust protection, including sterile immunity.
• Overcoming scientific and logistical hurdles requires sustained, cooperative efforts from researchers.